NEUPNasdaqPharmaceutical Preparations

Neuphoria Therapeutics Inc. (NEUP) earnings date, market-implied expected move, and options open interest by expiry

3.00

+0.01 · +0.33%

Regular session13:58 ET

Open2.99Volume7,872Mkt cap$16.2M

Day2.98 – 3.0529%52-wk2.99 – 5.530%

NEUP

Neuphoria Therapeutics Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

91dAre CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders?

News

Next report

Last report

—

Linked news

1dMRK · customerMerck Initiates Phase 3 Study Evaluating Ohtuvayre® (ensifentrine) for the Prevention of COPD Exacerbations in Adult Patients Receiving Standard of Care With a History of Exacerbations

News

Largest filed tie

13F top-10 QoQ

+14.23%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

Top fund weight

0.00%

NEUP weight · VTI

N-PORTJun 30 '26

No upcoming report date for Neuphoria Therapeutics (NEUP). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

per later filingQ3 FY25

75.08%per later filingnet margin · revenue +2163.42% QoQ

Revenue

$15M+2163.42% QoQ

Gross profit

$15M+2163.42% QoQ

100.00% margin

Operating income

$12M+423.40% QoQ

79.85% margin

Pre-tax income

$11M+678.80% QoQ

Net income

$11M+679.52% QoQ

75.08% margin

Operating expenses

$3M−30.77% QoQ

R&D $2M

SG&A $1M

Other expense

$796,218

Tax benefit

$81,186

Revenue$15M+2163.42%

Gross profit

$15M+2163.42%

100.00% margin

Operating income

$12M+423.40%

79.85% margin

Pre-tax income

$11M+678.80%

Net income

$11M+679.52%

75.08% margin

Cost of revenue

Operating expenses

$3M−30.77%

R&D $2M

SG&A $1M

Other expense

$796,218

Tax benefit$81,186

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Mar 31 '25 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 13:45 ET

Intraday

Event sensitivity

CPROF ×1.10· ±4.0% vs ±3.6% · 12 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±4.0%5 of 12×1.10

GDPgross domestic product±3.6%9 of 19×1.01

FOMCrate decision±3.5%4 of 14×0.96

NFPjobs report±2.7%3 of 10×0.74

PCEpersonal income & outlays±2.0%7 of 19×0.55

CPIconsumer prices±1.9%4 of 10×0.52

PPIproducer prices±1.7%4 of 10×0.47

Bar = avg |move| to ±4% · tick = ±3.6% avg day · ×base = |move| ÷ ±3.6% · min 6 releases

Earnings history

EPS -0.09 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	-0.09	—
Q1 FY25	—	-4.41	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod